|Previous Section||Index||Home Page|
Mike Penning: To ask the Secretary of State for Health what recent research his Department has (a) commissioned and (b) evaluated on the effectiveness of the human papilloma virus vaccine Gardasil. 
Dawn Primarolo: The Department commissioned the Health Protection Agency to carry out studies to examine the impact and cost effectiveness of introducing a human papilloma virus (HPV) vaccination programme. This work has been accepted for publication in the British Medical Journal.
The Joint Committee on Vaccination and Immunisation (JCVI) provided advice to the Department on the effectiveness of HPV vaccines, including Gardasil (Sanofi Pasteur MSD). JCVI considered data on vaccine efficacy from both published papers and unpublished clinical trial data.
Mike Penning: To ask the Secretary of State for Health what his most recent estimate is of the cost of delivering a course of treatment of the human papilloma virus vaccine Cervarix as part of the national immunisation programme. 
Dawn Primarolo: The cost of delivering a course of treatment of the human papilloma virus (HPV) vaccine will vary from primary care trust (PCT) to PCT depending on how they choose to implement the immunisation programme.
Mike Penning: To ask the Secretary of State for Health what factors underlay the decision not to issue catch-up Cervarix vaccinations against the human papilloma infection to female patients older than 18 years as part of the national immunisation programme. 
Dawn Primarolo: The human papilloma virus (HPV) vaccination programme will offer the HPV vaccine to girls and young women aged 12 to 18 years of age. We are currently considering the issues around offering the vaccine to those over 18 years of age, including the cost-effectiveness of such an intervention.
Mr. Lansley: To ask the Secretary of State for Health if he will publish the respective assessments of the cost and benefits of providing (a) Cervarix and (b) Gardasil as the human papilloma virus vaccine for the national immunisation programme. 
Dawn Primarolo: The cost-effectiveness analysis of introducing a Human Papilloma Virus (HPV) Vaccination programme in the United Kingdom carried out by the Health Protection Agency has been accepted for publication in the British Medical Journal and will be available shortly.
To ask the Secretary of State for Health with reference to his Departments June 2008 consultation on the proposed new arrangements for the provision of stoma and urology services and related services in primary care, whether his Department has
undertaken an impact assessment in respect of urology patients who use intermittent catheters to ensure that they will maintain the same level and quality of care provision; and if he will make a statement. 
Dawn Primarolo: In line with the Better Regulation Executive (BERR) guidelines on consultation, an impact assessment has been published alongside the consultation document entitled Proposed new arrangements under Part IX of the Drug Tariff for the provision of stoma and urology appliancesand related servicesin Primary Care June 2008, copies of this publication have already been placed in the Library. The proposals set out in the consultation reflect discussions with patients and healthcare professionalsas well as dispensing contractors, manufacturers and wholesalers. It is intended that any new arrangements for the provision of stoma and incontinence items in primary care will maintain patient care.
Ann Keen: The Department has made no estimate of the number of people diagnosed with colitis and with Crohns disease in Bexley, and information about the number of people diagnosed with these conditions is not collected centrally. The hon. Member may therefore wish to raise this issue with the Chief Executive of Bexley Care Trust.
Sandra Gidley: To ask the Secretary of State for Health (1) what work is being undertaken to (a) raise awareness of the benefits of specialist care and (b) support patient choice in referral to specialist centres in relation to liver disease; 
Ann Keen: We recognise that there is strong support for developing a national strategy for liver disease and are currently considering how best to take this forward in light of the changes committed to in High Quality Care for All, published on 30 June, copies of which are available in the Library.
Ann Keen: Information on the number of eligible medical graduates on the four year graduate entry course for whom a tuition fee was paid and the total cost of tuition fees paid for those students in the last two academic years is shown in the table.
|Analysis of tuition fees paid to NHS funded medical students by academic year|
|Four year graduate entry course|
|Academic year||Number of students||Amount paid for tuition fees (£)|
1. NHS student bursaries database only holds details of the course that the student was actually funded for in that academic year, accordingly all medical and dental students who intercalated (undertook a one year BSc course part way through their medical/dental course) in any academic year have to be included with the figures for the medical students (because the vast majority of intercalating students are medical students) as they cannot interrogate the data to clarify whether an intercalated student was a medical or dental student in previous or future academic years.
2. Some graduate students may undertake the under-graduate medical course. However, these students cannot be included in the figures in the table as the information recorded by NHS student bursaries only captures the course the students are attending and not the status of the student.
NHS Business Services Authority Student Bursaries Unit
Stephen Williams: To ask the Secretary of State for Health how much his Department expects to spend on paying graduate medical students university tuition fees in each of the next five years. 
Ann Keen: Information on the estimated number of medical graduate on the four year graduate entry course and the estimated amount of tuition fees, which may be paid for those students in the next five academic years is shown in the following table.
|Estimated amount of tuition fees which may be paid to national health service funded medical students on the four year graduate entry course by academic year|
|Academic year||Estimated number of graduates on the four-year graduate entry medical course( 1,2)||Estimated amount of tuition fees to be paid( 3,4) (£)|
|(1) Actual intake medical graduate numbers in 2005-06, 2006-07 and 2007-08 were used to estimate the number of medical graduates in 2008-09.|
(2) The planned intake medical graduate figure from 2007-06 was used to calculate estimated total number of medical graduates from 2008-09 onwards.
(3) Actual tuition fee rates have been used to estimate total amount of tuition fees paid in 2008-09 and 2009-10. From 2010-11 onwards, the 2009-10 tuition fee rate has been used to calculate estimated total amount of tuition fees paid and does not include any annual uplifts.
(4) The amount of tuition fee paid is calculated from the estimated number of medical graduates, however in reality not all medical graduates will be eligible to have their tuition fees paid.
1. The figures do not account for medical students who might intercalate (undertake a one year BSc course part way through their medical course) in any academic year and so this would increase the number of years they would need their tuition fees paid for them.
2. Some graduate students choose to undertake the under-graduate medical course because their degree is not acceptable for entry onto the shortened medical course. However, these students cannot be included in the figures in the table as the information recorded by Higher Education Funding Council only captures the course the students are attending and not the status of the student.
1. Higher Education Funding Council for England: Medical School Return 2004-052007-08
2. Department of Innovation Universities and Skills tuition fee rates 2006-072009-10
The Department published The Mental Health Policy Implementation Guidance in 2001 (copies of which have been deposited in the Library) to support the delivery of adult mental health policy locally and the joint publication with the Care Services Improvement Partnership Guidance Statement on Fidelity and Best Practice for Crisis Resolution Teams in January 2007. The Guidance Statement identifies aspects of how crisis teams deliver care which need attention so that best practice is followed across the country and emphasises a whole systems approach to care.
The information as to which mental health trusts have crisis resolution' and home treatment' teams is provided in the following table. The Department does not hold information on the numbers of emergency care' teams.
|Mental health services: total number of crisis teams per mental health provider at 31 March 2008|
|Mental health providers||Total crisis resolution teams|
Total crisis resolution teams include teams with Departments sign off to provide services to a population larger than a standard team as specified by the policy implementation guidance.
Service mapping exercise
|Next Section||Index||Home Page|